Evidence map›Paper›PMID 25422321›Full record

ArticleThe Journal of biological chemistry2015

Domain interactions control complex formation and polymerase specificity in the biosynthesis of the Escherichia coli O9a antigen.

Sean D Liston, Bradley R Clarke, Laura K Greenfield, Michele R Richards, Todd L Lowary, Chris Whitfield

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. O-antigen polysaccharides inMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  2. Article
  3. Identification of a second glycoform of the clinically prevalent O1 antigen fromProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  4. Article
  5. Article
  6. Lipopolysaccharide O-antigens-bacterial glycans made to measure.The Journal of biological chemistry · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Single polysaccharide assembly protein that integrates polymerization, termination, and chain-length quality control.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sean D ListonFrom the Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1 and.
Bradley R ClarkeFrom the Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1 and.
Laura K GreenfieldFrom the Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1 and.
Michele R Richardsthe Alberta Glycomics Centre and Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada.
Todd L Lowarythe Alberta Glycomics Centre and Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada.
Chris WhitfieldFrom the Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1 and cwhitfie@uoguelph.ca.
University of Guelph · CAAlberta Glycomics Centre · CAUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Escherichia coli O9a O-polysaccharide (O-PS) is a prototype for bacterial glycan synthesis and export by an ATP-binding cassette transporter-dependent pathway. The O9a O-PS possesses a tetrasaccharide repeat unit comprising two α-(1→2)- and two α-(1→3)-linked mannose residues and is extended on a polyisoprenoid lipid carrier by the action of a polymerase (WbdA) containing two glycosyltransferase active sites. The N-terminal domain of WbdA possesses α-(1→2)-mannosyltransferase activity, and we demonstrate in this study that the C-terminal domain is an α-(1→3)-mannosyltransferase. Previous studies established that the size of the O9a polysaccharide is determined by the chain-terminating dual kinase/methyltransferase (WbdD) that is tethered to the membrane and recruits WbdA into an active enzyme complex by protein-protein interactions. Here, we used bacterial two-hybrid analysis to identify a surface-exposed α-helix in the C-terminal mannosyltransferase domain of WbdA as the site of interaction with WbdD. However, the C-terminal domain was unable to interact with WbdD in the absence of its N-terminal partner. Through deletion analysis, we demonstrated that the α-(1→2)-mannosyltransferase activity of the N-terminal domain is regulated by the activity of the C-terminal α-(1→3)-mannosyltransferase. In mutants where the C-terminal catalytic site was deleted but the WbdD-interaction site remained, the N-terminal mannosyltransferase became an unrestricted polymerase, creating a novel polymer comprising only α-(1→2)-linked mannose residues. The WbdD protein therefore orchestrates critical localization and coordination of activities involved in chain extension and termination. Complex domain interactions are needed to position the polymerase components appropriately for assembly into a functional complex located at the cytoplasmic membrane.

Indexed as

Escherichia coliEscherichia coli ProteinsGlycosyltransferasesMannoseMethyltransferasesMultiprotein ComplexesO AntigensPolysaccharides, BacterialProtein Structure, SecondaryProtein Structure, TertiaryEscherichia coli ProteinsGlycosyltransferasesMannoseMethyltransferasesMultiprotein ComplexesO AntigensPolysaccharides, BacterialWbdD protein, E coliCarbohydrate BiosynthesisEnzyme StructureGlycobiologyGlycosyltransferaseLipopolysaccharide (LPS)MicrobiologyPolysaccharideProtein Complex

Identifiers

PMID25422321
PMCPMC4294475
OpenAlexW2082238379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.